Keyphrases
Alternative Substrates
16%
Binding Residues
16%
Carbohydrate Transport
16%
Chimera
16%
Co-conformations
16%
Combined Method
16%
Crystal Structure Prediction
16%
Diabetes
16%
Diagnostic Marker
16%
Functional Variability
16%
Gal2
16%
Glucose Transporter 1 (GLUT1)
100%
Glucose Transporter 9 (GLUT9)
100%
Glucose Transporter Family
16%
GLUT5
33%
In Silico Screening
16%
In Vitro Validation
16%
Inhibitor Specificity
16%
Investigative Tool
16%
Inward-facing Conformation
16%
Ligand Affinity
50%
Ligand Binding Site
33%
Ligand Docking
16%
Ligand Recognition
16%
Ligand Specificity
100%
Long-range Interactions
16%
Molecular Determinants
16%
Novel Inhibitors
16%
Obesity
16%
Outward-facing Conformation
16%
Pharmacological Control
16%
Potent Inhibitor
16%
Selective Ligands
16%
SLC2
16%
Small Molecule Libraries
16%
Specific Inhibitor
33%
Specific Intent
16%
Specific Ligands
66%
Specific Molecular Interactions
16%
Substrate Affinity
33%
Substrate Binding Site
16%
Substrate Specificity
50%
Therapeutic Target
16%
Tissue Distribution
16%
Transport Activity
16%
Transport Mechanism
16%
Transport System
16%
Biochemistry, Genetics and Molecular Biology
Binding Site
14%
Conformation
19%
Crystal Structure
9%
Glucose Transporter
100%
GLUT1
100%
GLUT5
9%
Ligand Binding
9%